Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 235,048 | 246,375 | 276,402 | 456,661 | 513,448 |
| Marketable Securities | 28,693 | 27,192 | 32,694 | 0 | N/A |
| Receivables | 278,849 | 272,370 | 259,327 | 263,465 | 231,831 |
| Inventories | 492,735 | 429,090 | 389,608 | 324,583 | 317,386 |
| Other current assets | 28,130 | 29,653 | 32,643 | 31,032 | 0 |
| TOTAL | $1,159,544 | $1,081,681 | $1,058,036 | $1,161,498 | $1,153,716 |
| Non-Current Assets | |||||
| PPE Net | 444,335 | 405,723 | 340,199 | 311,302 | 311,703 |
| Intangibles | 1,749,820 | 2,304,540 | 2,123,295 | 2,165,490 | 2,159,031 |
| Other Non-Current Assets | 248,302 | 245,480 | 260,458 | 251,468 | 157,933 |
| TOTAL | $2,442,457 | $2,955,743 | $2,723,952 | $2,728,260 | $2,628,667 |
| Total Assets | $3,602,001 | $4,037,424 | $3,781,988 | $3,889,758 | $3,782,383 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 87,800 | 573,170 | 0 | N/A | N/A |
| Accounts payable and accrued liabilities | 95,726 | 82,502 | 92,326 | 102,100 | 61,837 |
| Accrued Expenses | 204,572 | 207,525 | 176,299 | 158,804 | 213,114 |
| Other current liabilities | 11,463 | 10,483 | 8,540 | 7,253 | 5,295 |
| TOTAL | $455,981 | $922,126 | $306,980 | $320,906 | $340,021 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,729,556 | 1,196,017 | 914,763 | 837,849 | 936,757 |
| Other Non-Current Liabilities | 367,337 | 313,168 | 937,044 | 863,262 | 775,013 |
| TOTAL | $2,102,557 | $1,570,018 | $1,887,124 | $1,764,449 | $1,757,558 |
| Total Liabilities | $2,558,538 | $2,492,144 | $2,194,104 | $2,085,355 | $2,097,579 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 77,937 | 77,219 | 78,220 | 81,636 | 83,243 |
| Common Shares | 923 | 916 | 909 | 905 | 896 |
| Retained earnings | 423,441 | 939,915 | 946,859 | 879,118 | 698,568 |
| Other shareholders' equity | -30,287 | -27,982 | -15,368 | 10,403 | -45,603 |
| TOTAL | $1,043,463 | $1,545,280 | $1,587,884 | $1,804,403 | $1,684,804 |
| Total Liabilities And Equity | $3,602,001 | $4,037,424 | $3,781,988 | $3,889,758 | $3,782,383 |